Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acasti Pharma Inc (NASDAQ:ACST)

1.67
Delayed Data
As of 3:59pm ET
 +0.2599 / +18.43%
Today’s Change
1.20
Today|||52-Week Range
4.20
-34.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues127.4K725.0K478.6K240.5K
 
 
 
 
 
Cost of Goods Sold5.1K406.8K278.9K208.9K
 
 
 
 
 
Depreciation And Amortization673.4K665.7K1.7M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income-551.1K-347.6K-1.5M-2.0M
 
 
 
 
 
General Expenses6.5M7.0M9.1M9.2M
 
 
 
 
 
Research And Development3.6M3.4M4.4M6.0M
 
 
 
 
 
Total Operating Expenses7.2M8.1M11.1M11.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.0M-7.4M-10.6M-11.2M
 
 
 
 
 
Extraordinary Credit0.000.00--7.8M
 
 
Extraordinary Charge0.000.00-484.9K--
 
 
Interest Expense On Debt9.0K------
 
 
Other Expenses-22.5K40.2K-321.8K1.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.0M-7.3M-11.4M-1.7M
 
 
 
 
 
Income Taxes-457.1K-370.7K-257.6K-234.9K
 
 
 
 
 
Net Income-6.6M-6.9M-11.1M-1.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.7M7.3M8.4M10.6M
 
 
 
 
 
Shares To Calculate EPS Diluted6.7M7.3M8.4M10.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.01-$0.90-$1.34-$0.18
 
 
 
 
 
EPS Diluted-$1.01-$0.90-$1.34-$0.18